Loading...
NPI 1326280504 · Paducah, KY · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Landen Meeks is a ophthalmology physician provider located in Paducah, Kentucky. This profile covers 20 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Landen Meeks |
| Address | 4630 Village Square Dr |
| City | Paducah |
| State | KY |
| ZIP | 42001 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | April 2, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.2M |
| Medicaid | $4.9K |
This provider’s revenue profile is overwhelmingly Medicare-driven: total Medicare revenue is $2.2M versus total Medicaid revenue of $4.9K, so the practice is effectively single-payer from a scale perspective with Medicare accounting for virtually all billed dollars. The NPI was enumerated on 2009-04-02 (~17 years ago), indicating an established presence in PADUCAH, KY.
Revenue concentration on Medicare is extreme: the precomputed top 3 Medicare codes account for 76.2% of this provider’s Medicare revenue, driven primarily by J0178 ($1.2M, 53.0% of Medicare revenue), J2777 ($320.2K, 14.6%), and J2778 ($188.1K, 8.6%). This concentration points to heavy financial dependence on a small set of high-revenue biologic/injection codes rather than a broad mix of low-revenue services.
The payer-code mix and code descriptions indicate an operation focused on retina/intravitreal pharmacologic therapy and cataract care: J0178, J2777, and J2778 are intravitreal biologic injections and together dominate Medicare revenue, while 66984 (cataract extraction with IOL, $169.6K, 7.7% of Medicare revenue) indicates routine cataract surgery volumes are a secondary but material service line. The presence of 67028 (intravitreal injection as an isolated procedure, $99.1K) reinforces the injection-centric service model.
Competitive standing on the top injection code is modest: J0178 ranks #691 of 3204 providers nationally (78th percentile; typical, unremarkable volume), and both J2777 and J2778 are also characterized as typical, unremarkable volume at their national ranks. These rankings suggest the provider has solid, non-dominant throughput for anti-VEGF/faricimab/ranibizumab injections relative to national peers rather than being a regional or national leader.
Several evaluation/management codes are statistical outliers on Medicare: 99213 (1K claims, $58K revenue) ranks #5906 of 457151 providers (99th percentile; extreme outlier, far above typical national volume) and 99204 (306 claims, $31.8K revenue) also ranks in the 99th percentile and is labeled an extreme outlier. This indicates unusually high office visit E/M billing relative to most ophthalmology peers and may reflect either a high-volume clinic schedule or coding concentration on certain visit types.
Diagnostic imaging for posterior-segment care is notably above typical national volume: 92134 (1.5K claims, $41.8K revenue) ranks in the 95th percentile (notably above typical national volume), 92133 (360 claims, $8.3K) is also at the 95th percentile (notably above typical national volume), and 92136 is at the 94th percentile (notably above typical national volume). These patterns support a retina-focused practice with substantial imaging used to manage retinal disease.
Medicaid activity is minimal and concentrated in low-complexity outpatient visits: Medicaid billing is essentially all 99213 (138 claims, $35 avg paid/claim, $4.8K revenue), which represents 100.0% of the provider’s Medicaid revenue and ranks #2565 of 3339 providers in-state (23rd percentile; typical, unremarkable volume). This contrast with Medicare suggests limited Medicaid access or participation beyond basic office visits.
Overall, the combination of long tenure (~17 years), concentrated high-revenue injectable drug billing on Medicare (top 3 codes = 76.2% of Medicare revenue), above-typical posterior-segment imaging, and extreme national outlier status for certain E/M codes paints the picture of an established ophthalmology practice with a clinical emphasis on retina/injection services and cataract procedures, with very limited Medicaid engagement beyond routine established-patient visits.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
20 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,700 | $690 | $1.2M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 11,040 | $30 | $320.2K |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,040 | $180 | $188.1K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 600 | $290 | $169.6K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,110 | $90 | $99.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,040 | $60 | $58K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,550 | $30 | $41.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 310 | $100 | $31.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 380 | $80 | $30.3K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 100 | $280 | $27.5K |
Showing 1–10 of 20
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
20 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 15 | 40 | 870 | $690 | $858.5K |
| J2777 | 15 | 30 | 11,040 | $30 | $399.1K |
| J2778 | 5 | 20 | 700 | $180 | $148.3K |
| 67028 | 19 | 50 | 650 | $90 | $72.9K |
| 66984 | 204 | 310 | 1,560 | $40 | $67.1K |
| 66991 | 13 | 10 | 30 | $1,390 | $43K |
| J3590 | 16 | 40 | 160 | $60 | $17K |
| 66821 | 44 | 160 | 50 | $110 | $16.1K |
| 99214 | 1,007 | 7,230 | 110 | $70 | $14.1K |
| 92014 | 142 | 420 | 90 | $80 | $14K |
Showing 1–10 of 20
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 140 | $40 | $4.8K |
How this provider's Medicaid billing volume and revenue compare to other Kentucky providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kentucky median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,565 | 3,340 | 1,020 | $30 | $296K |
Other providers in the same ZIP code as Landen Meeks, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.